Quantum-Si incorporated
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule…
1D
-14.5%
1W
-26.8%
1M
+53.4%
6M
+4.7%
YTD
+1.8%
1Y
-55.9%
2Y
+37.2%
5Y
-87.0%
10Y
–
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~1% stronger price swings than usual
PRICE TARGET LOW
US$1.90
CONSENSUS
US$2.95
MEDIAN
US$2.95
PRICE TARGET HIGH
US$4.00
0
STRONG BUY
1
BUY
1
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 29/09/2026
P/E
-2.41
P/B
1.35
EV/EBITDA
-2.23
RETURN ON EQUITY
-13.1%
NET MARGIN
-6,841.3%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
86.1%
FLOAT SHARES
171,250,528
AVG. DAILY VOLUME (30D)
7,842,521
LaPointe Christian
LaPointe Christian
Keyes Jeffry R.
Keyes Jeffry R.
Hawkins Jeffrey Alan
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -14.5%
Forums (Reddit)
Quantum-Si incorporated is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Jeffrey Alan Hawkins, the company employs around 145 people.
The IPO was on 13/11/2020; the stock trades on NASDAQ under the ticker QSI.
2 analysts rate the stock, the consensus is Buy (as of 29/09/2026).
The average price target is US$2.95, ranging from US$1.90 to US$4.00, with a median of US$2.95.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 1% stronger than usual.
No, Quantum-Si currently does not pay a dividend.
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
Clicking "Analyze stock" lets five strategies assess Quantum-Si against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.